By
Thu Dec 17 2020
At least eight in 10 people would take a COVID-19 vaccine if it were deemed safe and effective, a survey shows.
The survey was conducted by Africa Centres for Disease Control and Prevention (Africa CDC), in partnership with the London School of Hygiene & Tropical Medicine (LSHTM).
Conducted between August and December 2020, the survey interviewed more than 15,000 adults, aged 18 years and above, across 15 African countries: Burkina Faso, Côte d’Ivoire, Democratic Republic of the Congo, Ethiopia, Gabon, Kenya, Malawi, Morocco, Niger, Nigeria, Senegal, South Africa, Sudan, Tunisia, and Uganda.
Data from the survey shows significant variations in willingness across countries and across the five regions in the continent, from 94% and 93%, respectively, in Ethiopia and Niger to 65% and 59%, respectively, in Senegal and the Democratic Republic of Congo.
Africa: Here s Why 8 in 10 Africans Are Ready to Take Covid-19 Vaccine allafrica.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from allafrica.com Daily Mail and Mail on Sunday newspapers.
Coronavirus vaccines: Your questions answered
There is sorely needed good news on the vaccine front: A second US vaccine has been found to have a high success rate against Covid-19..
Posted: Nov 17, 2020 9:25 AM
Updated: Nov 17, 2020 9:45 AM
Posted By: CNN
There is sorely needed good news on the vaccine front: A second US vaccine has been found to have a high success rate against Covid-19. Moderna announced on Monday that its vaccine was 94.5% effective against coronavirus, according to early data.
Vaccinations could begin in the United States in the second half of December, starting with high-risk groups and becoming available for the rest of the population in spring, according to Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases.
Books: 667 | Lavender Magazine lavendermagazine.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lavendermagazine.com Daily Mail and Mail on Sunday newspapers.
Wednesday, December 16, 2020 10:00 am - 11:00 am
In the face of rising cases of Covid-19 across the United States, many are hoping that the approval of a novel coronavirus vaccine, or vaccines, in 2021 may offer a way to move beyond the worst effects of the pandemic. Yet recent polls indicate that despite confidence-building measures by government officials, pharmaceutical companies, and social media platforms, public trust in a vaccine remains in doubt. Please join the CSIS-LSHTM High-Level Panel on Vaccine Confidence and Misinformation on
Wednesday, December 16, from 10:00 to 11:00 a.m. EST for a discussion of the panel’s first proposal in its recently released Call to Action: that Congress or a non-governmental entity convene an independent, bipartisan review panel to strengthen public trust and confidence in Covid-19 vaccines in the United States, by assessing the root causes of vaccine hesitancy and identifying concrete steps to be taken at the national, state, and local le